What is the global meningococcal vaccines Market in 2025?

The global meningococcal vaccines market is projected to be valued at US$ 4.4 billion in 2025.

What drives the global meningococcal vaccines market?

Rise in meningococcal disease incidence, government vaccination programs, public-private collaborations, and the development of next-generation vaccines drive the global market.

What is the growth rate for the global meningococcal vaccines market?

The global meningococcal vaccines market is poised to witness a CAGR of 6.2% between 2025 and 2032.

What are the key meningococcal vaccines market opportunities?

Expanding immunization policies, novel combination vaccines, clinical trials in emerging markets, and increasing awareness in under-vaccinated populations offer lucrative opportunities.

Who are the key players in the global meningococcal vaccines market?

Major players in the global meningococcal vaccines market are Pfizer Inc., GSK, Serum Institute of India Pvt. Ltd, Sanofi Pasteur Inc., and others.

Table of Content - Meningococcal Vaccines Market Size, Trends, Share, Growth, and Regional Forecast, 2025 to 2032

Executive Summary
1. Global Meningococcal Vaccines Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. Pipeline Analysis
6. PESTLE Analysis
7. Porter’s Five Force Analysis
Global Meningococcal Vaccines Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
3. Global Meningococcal Vaccines Market Outlook: Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
    1. Meningococcal Polysaccharide Vaccine
    2. Meningococcal Conjugate Vaccine
    3. Serogroup B Meningococcal Vaccine
  4. Market Attractiveness Analysis: Product
4. Global Meningococcal Vaccines Market Outlook: Age Group
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Age Group, 2019-2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
    1. Infants (0-24 months)
    2. Children (2-12 years)
    3. Adolescents and Young Adults
    4. Adults
  4. Market Attractiveness Analysis: Age Group
5. Global Meningococcal Vaccines Market Outlook: Distribution Channel
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019-2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  4. Market Attractiveness Analysis: Distribution Channel
Global Meningococcal Vaccines Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product
  3. By Age Group
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
  1. Infants (0-24 months)
  2. Children (2-12 years)
  3. Adolescents and Young Adults
  4. Adults
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Europe Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product
  3. By Age Group
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
  1. Infants (0-24 months)
  2. Children (2-12 years)
  3. Adolescents and Young Adults
  4. Adults
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
East Asia Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product
  3. By Age Group
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
  1. Infants (0-24 months)
  2. Children (2-12 years)
  3. Adolescents and Young Adults
  4. Adults
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
South Asia & Oceania Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product
  3. By Age Group
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
  1. Infants (0-24 months)
  2. Children (2-12 years)
  3. Adolescents and Young Adults
  4. Adults
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Latin America Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product
  3. By Age Group
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
  1. Infants (0-24 months)
  2. Children (2-12 years)
  3. Adolescents and Young Adults
  4. Adults
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Middle East & Africa Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product
  3. By Age Group
  4. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Mn) Analysis and Forecast, By Age Group, 2025-2032
  1. Infants (0-24 months)
  2. Children (2-12 years)
  3. Adolescents and Young Adults
  4. Adults
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Pfizer Inc.
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. GSK
  3. Serum Institute of India Pvt. Ltd
  4. Sanofi Pasteur Inc.
  5. CansinoBl0
  6. BIO-MED
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Meningococcal Vaccines Market Size, Trends, Share, Growth, and Regional Forecast, 2025 to 2032

Meningococcal Vaccines Market by Product (Meningococcal Polysaccharide Vaccine, Meningococcal Conjugate Vaccine, Serogroup B Meningococcal Vaccine), Age Group, Distribution Channel and Regional Analysis from 2025 to 2032

Quick Links

Our Partners

Secure Payments Through